Galderma Group AG
GALD
Rank in Stocks
#459
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Share Price
$224.81
Market Cap
$52.42B
Change (1 day)
6.31%
Change (1 year)
31.28%
Country
CH
Trade Galderma Group AG (GALD)
Category
Healthcare
Dividend history for Galderma Group AG (GALD)
Galderma Group AG (stock symbol: GALD) made a total of 2 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.50
Dividend yield (TTM) : 0.0019
The sum of all dividends (adjusted for stock splits) is : $0.50
Dividend yield (TTM) : 0.0019
Dividend payments for Galderma Group AG (GALD) from 2025 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.35 | 133.33% |
| 2025 | $0.15 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.35 | 133.33% |
| 2025 | $0.15 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 13.00% |
DE
|
|
| 26.00% |
DE
|
|
| 55.00% |
JP
|
|
| 39.00% |
IN
|
|
| 26.00% |
CN
|
